Takeda Pharmaceutical Company Limited (LON:0A87)
London flag London · Delayed Price · Currency is GBP · Price in USD
13.93
-1.05 (-7.01%)
At close: Apr 7, 2025

LON:0A87 Statistics

Total Valuation

LON:0A87 has a market cap or net worth of GBP 32.17 billion. The enterprise value is 56.10 billion.

Market Cap 32.17B
Enterprise Value 56.10B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +1.58%
Shares Change (QoQ) -0.21%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.57B

Valuation Ratios

The trailing PE ratio is 57.67.

PE Ratio 57.67
Forward PE n/a
PS Ratio 1.36
PB Ratio 0.90
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.10, with an EV/FCF ratio of 12.67.

EV / Earnings 100.57
EV / Sales 2.40
EV / EBITDA 9.10
EV / EBIT 24.66
EV / FCF 12.67

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.73.

Current Ratio 1.01
Quick Ratio 0.44
Debt / Equity 0.73
Debt / EBITDA 4.19
Debt / FCF 5.92
Interest Coverage 4.15

Financial Efficiency

Return on equity (ROE) is 1.52% and return on invested capital (ROIC) is 2.27%.

Return on Equity (ROE) 1.52%
Return on Assets (ROA) 1.91%
Return on Invested Capital (ROIC) 2.27%
Return on Capital Employed (ROCE) 3.82%
Revenue Per Employee 480,515
Profits Per Employee 11,320
Employee Count 49,281
Asset Turnover 0.31
Inventory Turnover 1.30

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.58% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +2.58%
50-Day Moving Average 13.46
200-Day Moving Average 13.72
Relative Strength Index (RSI) 53.80
Average Volume (20 Days) 2,192

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, LON:0A87 had revenue of GBP 23.68 billion and earned 557.84 million in profits. Earnings per share was 0.35.

Revenue 23.68B
Gross Profit 15.51B
Operating Income 2.32B
Pretax Income 904.94M
Net Income 557.84M
EBITDA 6.26B
EBIT 2.32B
Earnings Per Share (EPS) 0.35
Full Income Statement

Balance Sheet

The company has 1.99 billion in cash and 26.19 billion in debt, giving a net cash position of -24.19 billion.

Cash & Cash Equivalents 1.99B
Total Debt 26.19B
Net Cash -24.19B
Net Cash Per Share n/a
Equity (Book Value) 35.85B
Book Value Per Share 22.61
Working Capital 75.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.46 billion and capital expenditures -1.04 billion, giving a free cash flow of 4.43 billion.

Operating Cash Flow 5.46B
Capital Expenditures -1.04B
Free Cash Flow 4.43B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 65.51%, with operating and profit margins of 9.80% and 2.36%.

Gross Margin 65.51%
Operating Margin 9.80%
Pretax Margin 3.82%
Profit Margin 2.36%
EBITDA Margin 26.42%
EBIT Margin 9.80%
FCF Margin 18.69%

Dividends & Yields

This stock pays an annual dividend of 0.21, which amounts to a dividend yield of 1.52%.

Dividend Per Share 0.21
Dividend Yield 1.52%
Dividend Growth (YoY) -7.34%
Years of Dividend Growth n/a
Payout Ratio 280.28%
Buyback Yield -1.58%
Shareholder Yield -0.06%
Earnings Yield 1.73%
FCF Yield 13.76%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

LON:0A87 has an Altman Z-Score of 1.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.09
Piotroski F-Score n/a